Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in

  News Archive

CyTuVax Reports Interim Results of the Phase I Clinical Trial
Tuesday, May 10, 2016
Company has reported the interim results of a phase I clinical trial assessing the safety and efficacy of Hepatitis B HBAI20 vaccine for non- responders.

First Patient Dosed in Phase II Clinical Trial in SAH
Saturday, May 07, 2016
Company has announced the first patient has been dosed in the company’s Phase II clinical trial of SFX-01.

AACR 2016: Cancer Immunotherapy and Beyond
Friday, May 06, 2016
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).

Concept Life Sciences Group Offers Unrivalled Expertise as a Strategic Partner
Wednesday, May 04, 2016
Company has announced that it will offer a comprehensive range of services to clients in the pharmaceutical, biotech, agrochemical, petrochemical, chemical, food, environmental and consumer industries.

Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma
Tuesday, May 03, 2016
Company has announced that it will evaluate the safety and tolerability and explore the preliminary efficacy of TB-403 for the treatment of relapsed or refractory medulloblastoma.

Aptuit Announces Acquisition of Exquiron Biotech AG
Friday, April 29, 2016
Company has announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services.

Recursion Announce Agreement With Sanofi Genzyme
Friday, April 29, 2016
Company has announced a research agreement with Sanofi to deploy its drug repurposing platform to identify new uses for Sanofi’s clinical stage molecules across dozens of genetic diseases.

CytomX, AbbVie Announce Collaboration
Friday, April 29, 2016
Company has announced collaboration with AbbVie to co-develop and co-commercialize Probody™ Drug Conjugates against CD71.

IBC Generium Selects Goodwin Biotechnology
Friday, April 29, 2016
Company has selected Goodwin Biotechnology to optimize the process, scale-up, and manufacture an IgG-based bispecific antibody for phase I clinical trials.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 4312

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos